Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy

IntroductionGender-affirming hormone therapy (GAHT) and gender-affirming surgery (GAS) may be desired by transgender and gender-diverse (TGD) individuals who want to affirm their gender identity. Testosterone is the basis of GAHT for transgender individuals assigned female at birth (AFAB), whereas G...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Elena Sanna, Alessandra Lami, Giulia Giacomelli, Stefania Alvisi, Alexandro Paccapelo, Renato Seracchioli, Maria Cristina Meriggiola
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-09-01
Edice:	Frontiers in Endocrinology
Témata:	bone health transgender assigned female at birth (AFAB) testosterone Dual-energy X-ray absorptiometry (DXA) gender affirming hormonal therapy (GAHT)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1416121/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!